What is it about?
This study aimed to examine the relationship between epicardial adipose tissue (EAT) volume and density measured on thoracic CT scans and the prognosis of nonelderly patients with severe COVID-19. The study included 190 patients admitted to the ICU between March 2020 and January 2022. Results showed that both EAT volume and density were significantly higher in patients who died compared to those who were discharged. The findings suggest that measuring EATV and EATA could potentially be used as predictors of mortality in nonelderly patients with severe COVID-19.
Photo by Robina Weermeijer on Unsplash
Why is it important?
This study is important because it explores the potential role of epicardial adipose tissue (EAT) in predicting the prognosis of nonelderly patients with severe COVID-19. Understanding the relationship between EAT and disease outcomes could provide valuable insights into the underlying mechanisms and identify potential biomarkers for risk stratification. If EAT volume and density measurements on thoracic CT scans prove to be reliable predictors of mortality, they could aid healthcare professionals in identifying high-risk patients early on and tailoring treatment strategies accordingly. This could potentially improve patient outcomes and resource allocation in the management of severe COVID-19 cases.
Read the Original
This page is a summary of: Is there a relationship between epicardial adipose tissue, inflammatory markers and prognosis in COVID-19 in patients under 65 years?, Biomarkers in Medicine, August 2022, Future Medicine, DOI: 10.2217/bmm-2022-0237.
You can read the full text:
The following have contributed to this page